Intracranial germ cell tumors.

Area of Science:

• Neuro-oncology
• Pediatric oncology
• Radiation oncology

Background:

• Intracranial germ cell tumors (IGCTs) are diverse, affecting both children and adults.
• Diagnosis often requires histology, though tumor markers like alpha-fetoprotein and beta-human chorionic gonadotropin can aid diagnosis.
• Prognoses and management strategies differ significantly among IGCT subtypes.

Purpose of the Study:

• To review the current understanding of intracranial germ cell tumors.
• To discuss diagnostic approaches, including the role of tumor markers.
• To outline management strategies and prognoses for different IGCT subtypes.

Main Methods:

• Review of existing literature on intracranial germ cell tumors.
• Analysis of diagnostic criteria and therapeutic outcomes.
• Comparison of treatment efficacy for germinomas versus nongerminomatous germ cell tumors.

Main Results:

• Germinomas demonstrate a favorable prognosis, with over 90% achieving effective treatment with radiation therapy.
• Chemosensitivity of germinomas suggests chemotherapy can potentially reduce radiation doses.
• Nongerminomatous germ cell tumors have a less favorable outcome; radiation alone achieves 40%-60% disease control, with chemotherapy potentially improving survival.

Conclusions:

• Germinomas are highly responsive to radiation therapy, and combined-modality treatment with chemotherapy may allow for reduced radiation volumes.
• Management of nongerminomatous germ cell tumors remains challenging, with combined chemotherapy and radiation therapy offering improved survival rates.
• Further research is needed to establish optimal radiation doses and volumes for IGCTs.